130 related articles for article (PubMed ID: 34414457)
21. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA‑720 inhibits pancreatic cancer cell proliferation and invasion by directly targeting cyclin D1.
Zhang Y; Su Y; Zhao Y; Lv G; Luo Y
Mol Med Rep; 2017 Dec; 16(6):9256-9262. PubMed ID: 28990111
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
[TBL] [Abstract][Full Text] [Related]
26. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene.
Liu X; Lv XB; Wang XP; Sang Y; Xu S; Hu K; Wu M; Liang Y; Liu P; Tang J; Lu WH; Feng QS; Chen LZ; Qian CN; Bei JX; Kang T; Zeng YX
Cell Cycle; 2012 Jul; 11(13):2495-506. PubMed ID: 22739938
[TBL] [Abstract][Full Text] [Related]
27. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
[TBL] [Abstract][Full Text] [Related]
28. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
29. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-490-5P Targets CCND1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.
Zhao L; Tang X; Luo R; Duan J; Wang Y; Yang B
Curr Neurovasc Res; 2018; 15(3):246-255. PubMed ID: 30101705
[TBL] [Abstract][Full Text] [Related]
31. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.
Cai CK; Zhao GY; Tian LY; Liu L; Yan K; Ma YL; Ji ZW; Li XX; Han K; Gao J; Qiu XC; Fan QY; Yang TT; Ma BA
Oncol Rep; 2012 Nov; 28(5):1764-70. PubMed ID: 22922827
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-519d-3p inhibits cell proliferation and cell cycle G1/S transition in glioma by targeting CCND1.
Ma L; Li J
Biosci Biotechnol Biochem; 2020 Feb; 84(2):297-304. PubMed ID: 31661371
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma.
Wang MT; Chen G; An SJ; Chen ZH; Huang ZM; Xiao P; Ben XS; Xie Z; Chen SL; Luo DL; Tang JM; Lin JY; Zhang XC; Wu YL
Dis Esophagus; 2012; 25(7):664-70. PubMed ID: 22150974
[TBL] [Abstract][Full Text] [Related]
34. Tetrandrine inhibits colon carcinoma HT-29 cells growth via the Bcl-2/Caspase 3/PARP pathway and G1/S phase.
Li J; Wang Q; Wang Z; Cui N; Yang B; Niu W; Kuang H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31040202
[TBL] [Abstract][Full Text] [Related]
35. Identification of GSPT1 as prognostic biomarker and promoter of malignant colon cancer cell phenotypes via the GSK-3β/CyclinD1 pathway.
Long X; Zhao L; Li G; Wang Z; Deng Z
Aging (Albany NY); 2021 Apr; 13(7):10354-10368. PubMed ID: 33819920
[TBL] [Abstract][Full Text] [Related]
36. Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer.
Fusté NP; Castelblanco E; Felip I; Santacana M; Fernández-Hernández R; Gatius S; Pedraza N; Pallarés J; Cemeli T; Valls J; Tarres M; Ferrezuelo F; Dolcet X; Matias-Guiu X; Garí E
Oncotarget; 2016 May; 7(19):26979-91. PubMed ID: 27105504
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
Guo F; Fu Q; Wang Y; Sui G
J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
[TBL] [Abstract][Full Text] [Related]
40. Let‑7i‑5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikrein‑related peptidase 6.
Song J; Wang L; Ma Q; Yang Y; Yang Z; Wang B; He N
Oncol Rep; 2018 Sep; 40(3):1459-1466. PubMed ID: 30015976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
